CompanyDrug

Fosun Pharmaceutical’s FCN-159 Earns Breakthrough Therapy Designation for Histiocyte Tumors

CompanyDrug

Aosaikang Pharmaceutical Receives NMPA Review for ASKC200 Liniment from Propella Therapeutics

CompanyR&D

HuidaGene Therapeutics Enhances CRISPR-Cas12f System with Higher Editing Efficiency

CompanyDeals

Shanghai’s PharmaLegacy Files for IPO on STAR, Targets Pre-clinical R&D Expansion

Company

Huadong Medicine Reports 9.12% YOY Revenue Growth and 13.24% Increase in Net Profits for 2022

Company

BeiGene Launches LATAM Expansion with New Office in São Paulo, Brazil

CompanyR&D

Diapin Therapeutics Announces Breakthrough Preclinical Results for DT-109 in NASH Treatment

CompanyDrug

Convalife Pharmaceuticals’ Mefuparib Earns Orphan Drug Designation for Cholangiocarcinoma

CompanyDeals

VintaBio Secures $64M Funding to Revolutionize Viral Vectors for Cell and Gene Therapy

CompanyDeals

Alebund Pharmaceuticals Secures $29M in Pre-Series C Funding and $116M Loan for R&D and Manufacturing

CompanyDrug

Overland ADCT BioPharma Achieves Primary Endpoint in Zynlonta Phase II Study for R/R DLBCL

CompanyDrug

Novartis’ Jakavi Secures NMPA Approval for Acute GVHD Treatment in China